Common heart pill could block deadly skin cancer spread
NCT ID NCT06157099
Summary
This study is testing whether atorvastatin, a drug commonly used to lower cholesterol, can prevent melanoma skin cancer from spreading (metastasizing) in people who have had it surgically removed but are at high risk of it returning. About 150 participants who have had surgery for high-risk stage II or III melanoma will take either atorvastatin or a placebo pill daily for up to 5 years. Researchers will track if the drug helps keep the cancer from coming back and improves survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
Conditions
Explore the condition pages connected to this study.